Simultaneous uPAR and HER2/neu gene amplification on circulating cancer cells, as well as in primary tumor cells, has also been described in advanced metastatic breast cancer (MBC) patients and similarly associated with tumor recurrence, enhanced metastatic potential, and unfavorable outcomes [154]. The gene discussed is ERBB2; the disease is cancer.